Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Debiopharm and Ipsen announced renewal of their Decapeptyl® agreement, which extends their partnership through 2034 for the development, manufacturing and distribution of Decapeptyl®.
read more
nanoComposix recently received its Drug Manufacturing License from the Food and Drug Branch of the State of California Department of Public Health.
read more
Lonza announced an investment in a major expansion of Highly Potent API (HPAPI) capacity at its Visp, CH site.
read more
IVERIC bio and Catalent Biologics have entered into an agreement for production and manufacturing of GMP-grade AAV vector for IVERIC bio’s gene therapy product candidates, IC-100.
read more
Lannett has informed the approximately 80 employees at its Cody Labs subsidiary it has decided to cease operations and close its facility in Wyoming.
read more
Lyophilization Services of New England (LSNE) announced the acquisition of a sterile injectables manufacturing facility located in León, Spain.
read more
BiondVax Pharmaceuticals announced a patent covering production processes of the Company's M-001 universal influenza vaccine candidate was allowed in the USA and Japan.
read more
Concept Life Sciences has opened a new clinical and niche commercial facility to support pharmaceutical and biotechnology companies throughout the development and manufacture of API.
read more
Seqens will open a 366,000-square-foot lab today that is close to Paris and will serve as the company’s center of excellence in its Porcheville facility.
read more
iBio announced the activation of its new cGMP sterile fill-finish services operation via the signing of a supply agreement with a clinical-stage biopharmaceutical company.
read more
Catalent has agreed to purchase Bristol-Myers Squibb’s oral solid, biologics, and sterile product manufacturing and packaging facility in Anagni, Italy.
read more
After investing more than 100 million U.S. dollars, Sartorius started up its expanded manufacturing operations in Yauco, Puerto Rico.
read more
Gamida Cell and Lonza announced that the companies have entered into a strategic manufacturing agreement.
read more
Axovant Gene Therapies has signed a strategic partnership with Yposkesi a CDMO for preferred access and reserved capacity for cGMP grade viral vector production.
read more
PPS announced the Grand Opening of a new wing at the Riverview site dedicated to the production of HPAPIs with low Occupational Exposure Levels.
read more